A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

Mise à jour : Il y a 4 ans
Référence : NCT01223911

Femme et Homme

Extrait

This trial is conducted in Europe. The aim of this clinical trial is to investigate the safety, tolerability and pharmacokinetics (at which rate the drug is eliminated from the body) of NNC 151-0000-0000 in subjects with rheumatoid arthritis (RA).


Critère d'inclusion

  • Inflammation ,Rheumatoid Arthritis


Liens